Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Thirty years on: HIV receptor gymnastics and the prevention of infection
Robin A. Weiss
BMC BIOLOGY (2013)
Introduction of Exogenous T-cell Receptors Into Human Hematopoietic Progenitors Results in Exclusion of Endogenous T-cell Receptor Expression
Dimitrios N. Vatakis et al.
MOLECULAR THERAPY (2013)
Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
Lijing Li et al.
MOLECULAR THERAPY (2013)
Knockdown of HPRT for Selection of Genetically Modified Human Hematopoietic Progenitor Cells
Rashmi Choudhary et al.
PLOS ONE (2013)
A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
Felipe Garcia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Genetic Modification of Mouse Bone Marrow by Lentiviral Vector-Mediated Delivery of Hypoxanthine-Guanine Phosphoribosyltransferase Short Hairpin RNA Confers Chemoprotection Against 6-Thioguanine Cytotoxicity
K. Hacke et al.
TRANSPLANTATION PROCEEDINGS (2013)
Endogenous MCM7 MicroRNA Cluster as a Novel Platform to Multiplex Small Interfering and Nucleolar RNAs for Combinational HIV-1 Gene Therapy
Janet Chung et al.
HUMAN GENE THERAPY (2012)
Small Molecules and Big Killers: The Challenge of Eliminating the Latent HIV Reservoir
Stephen A. Migueles et al.
IMMUNITY (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
John Scholler et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Therapeutic vaccines against HIV infection
Felipe Garcia et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem Cells
Scott G. Kitchen et al.
PLOS PATHOGENS (2012)
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine
Laura Papagno et al.
AIDS (2011)
HIV Infection, Inflammation, Immunosenescence, and Aging
Steven G. Deeks
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Kristina Allers et al.
BLOOD (2011)
Clinical use of CCR5 inhibitors in HIV and beyond
Bruce L. Gilliam et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Targeted genome editing in pluripotent stem cells using zinc-finger nucleases
Sylwia Bobis-Wozowicz et al.
METHODS (2011)
Engineering HIV-Resistant Human CD4+T Cells with CXCR4-Specific Zinc-Finger Nucleases
Craig B. Wilen et al.
PLOS PATHOGENS (2011)
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model
Saki Shimizu et al.
BLOOD (2010)
Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo
H-P Kiem et al.
GENE THERAPY (2010)
Rapid T Cell Receptor Delineation Reveals Clonal Expansion Limitation of the Magnitude of the HIV-1-Specific CD8+ T Cell Response
Arumugam Balamurugan et al.
JOURNAL OF IMMUNOLOGY (2010)
Inhibition of In Vivo HIV Infection in Humanized Mice by Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody
Aviva Joseph et al.
JOURNAL OF VIROLOGY (2010)
Antiretroviral therapy and management of HIV infection
Paul A. Volberding et al.
LANCET (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
Didier Trono et al.
SCIENCE (2010)
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David L. DiGiusto et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components
Martha R. Neagu et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
Ronald T. Mitsuyasu et al.
NATURE MEDICINE (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants
Matthew W. McNatt et al.
PLOS PATHOGENS (2009)
Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5α (TRIM 5α) in CD34+ cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue
Joseph Anderson et al.
HUMAN GENE THERAPY (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
Angel Varela-Rohena et al.
NATURE MEDICINE (2008)
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus
Jan van Lunzen et al.
MOLECULAR THERAPY (2007)
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes
Leonia Bozzacco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Silencing of HIV-1 with RNA interference: A multiple shRNA approach
Olivier ter Brake et al.
MOLECULAR THERAPY (2006)
T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery
C. H. Swan et al.
GENE THERAPY (2006)
Removal of arginine 332 allows human TRIM5α to bind human immunodeficiency virus capsids and to restrict infection
Yuan Li et al.
JOURNAL OF VIROLOGY (2006)
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection
S Kinloch-de Loes et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cells
GM Podsakoff et al.
MOLECULAR THERAPY (2005)
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)
R Schröfelbauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition
AT Das et al.
JOURNAL OF VIROLOGY (2004)
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
M Stremlau et al.
NATURE (2004)
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
M Egelhofer et al.
JOURNAL OF VIROLOGY (2004)
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5
XF Qin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Modulation of HIV-1 replication by RNA interference
JM Jacque et al.
NATURE (2002)
Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection
R Schroers et al.
GENE THERAPY (2002)
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome
EM Kang et al.
BLOOD (2002)
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
LJN Cooper et al.
JOURNAL OF VIROLOGY (2000)
Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo
JR Bai et al.
MOLECULAR THERAPY (2000)